|
1
|
De Martel C, Maucort-Boulch D, Plummer M
and Franceschi S: World-wide relative contribution of hepatitis B
and C viruses in hepatocellular carcinoma. Hepatology.
62:1190–1200. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanism of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumour-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
St Laurent G, Wahlestedt C and Kapranov P:
The landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ryaboshapkina M and Hammar M: Human
hepatic gene expression signature of non-alcoholic fatty liver
disease progression, a meta-analysis. Sci Rep. 7:123612017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fan Q and Liu B: Identification of a
RNA-Seq based 8-long non-coding RNA signature predicting survival
in esophageal cancer. Med Sci Monit. 22:5163–5172. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Klingenberg M, Groß M, Goyal A,
Polycarpou-Schwarz M, Miersch T, Ernst A, Leupold J, Patil N,
Warnken U, Allgayer H, et al: The long noncoding RNA cancer
susceptibility 9 and RNA binding protein heterogeneous nuclear
ribonucleoprotein L form a complex and coregulate genes linked to
AKT signaling. Hepatology. 68:1817–1832. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lim LJ, Wong SYS, Huang F, Lim S, Chong
SS, Ooi LL, Kon OL and Lee CG: Roles and regulation of long
noncoding RNAs in hepatocellular carcinoma. Cancer Res.
79:5131–5139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cui K, Jin S, Du Y, Yu J, Feng H, Fan Q
and Ma W: Long noncoding RNA DIO3OS interacts with miR-122 to
promote proliferation and invasion of pancreatic cancer cells
through upregulating ALDOA. Cancer Cell Int. 19:2022019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He J, Zuo Q, Hu B, Jin H, Wang C, Cheng Z,
Deng X, Yang C, Ruan H, Yu C, et al: A noval, liver-specific long
noncoding RNA LINC01093 suppresses HCC progression by interaction
with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Lett.
450:98–109. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang YL, Li L, Jia YX, Zhang BZ, Li JC,
Zhu YH, Li MQ, He JZ, Zeng TT, Ban XJ, et al: LIN01554-mediated
glucose metabolism reprogramming suppresses tumourigenicity in
hepatocellular carcinoma via downregulating PKM2 expression and
inhibiting Akt/mTOR signaling pathway. Theranostics. 9:796–810.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Labernadie A, Kato T, Brugues A,
Serra-Picamal X, Derzsi S, Arwert E, Weston A, Gonzalez-Tarrago V,
Elosegui-Artola A, Albertazzi L, et al: A mechanically active
heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to
drive cancer cell invasion. Nat Cell Biol. 19:224–237. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saitoh M: Involvement of partial EMT in
cancer progression. J Biochem. 164:257–264. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng N, Li Y and Han ZG: Argonaute2
promotes tumour metastasis by way of up-regulating focal adhesion
kinase expression in hepatocellular carcinoma. Hepatology.
57:1906–1918. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu YA, Liang BY, Guan Y, You J, Zhu L,
Chen XP and Huang ZY: Loss of N-cadherin is associated with loss of
E-cadherin expression and poor outcomes of liver resection in
hepatocellular carcinoma. J Surg Res. 194:167–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cho ES, Kang HE, Kim NH and Yook JI:
Therapeutic implications of cancer epithelial-mesenchymal
transition (EMT). Arch Pharm Res. 42:14–24. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu S, Yang D, Ye Y, Liu P, Chen Z, Lei T,
Pu J, Liu L and Wang Z: Long noncoding RNA actin
filament-associated protein 1 antisense RNA 1 promotes malignant
phenotype through binging with lysine-specific demethylase 1 and
repressing HMG box-containing protein 1 in non-small-cell lung
cancer. Cancer Sci. 110:2211–2225. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang YH, He GL, Huang SZ, Zhong KB, Liao
H, Cai L, Gao Y, Peng ZW and Fu SJ: The long noncoding RNA AK002107
negatively modulates miR-140-5p and targets TGFBR1 to induce
epithelial-mesenchymal transition in hepatocellular carcinoma. Mol
Oncol. 13:1296–1310. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J, Le TD, Liu L and Li J: Inferring
and analysing module-specific lncRNA-mRNA causal regulatory
networks in human cancer. Brief Bioinform. 20:1403–1419. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen J, Rajasekaran M, Xia H, Zhang X,
Kong SN, Sekar K, Seshachalam VP, Deivasigamani A, Goh BKP, Ooi LL,
et al: The microtubule-associated protein PRC1 promotes early
recurrence of hepatocellular carcinomain association with the
Wnt/β-catenin signalling pathway. Gut. 65:1522–1534. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang J, Cai H, Sun L, Zhan P, Chen M,
Zhang F, Ran Y and Wan J: LGR5, a novel functional glioma stem cell
marker, promotes EMT by activating the Wnt/β-catenin pathway and
predicts poor survival of glioma patients. J Exp Clin Cancer Res.
37:2252018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Heuberger J and Birchmeier W: Interplay of
cadherin-mediated cell adhesion and canonical Wnt signaling. Cold
Spring Harb Perspect Biol. 2:a0029152010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Z, Zhou C, Chang Y, Zhang Z, Hu Y,
Zhang F, Lu Y, Zheng L, Zhang W and Li X and Li X: Long non-coding
RNA CASC11 interacts with hnRNA-K and activates the WNT/β-catenin
pathway to promote growth and metastasis in colorectal cancer.
Cancer Lett. 376:62–73. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen L, Guo P, He Y, Chen Z, Chen L, Luo
Y, Qi L, Liu Y, Wu Q, Cui Y, et al: HCC-derived exosomes elicit HCC
progression and recurrence by epithelial-mesenchymal transition
through MAPK/ERK signaling pathway. Cell Death Dis. 9:5132018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding D, Huang H, Jiang W, Yu W, Zhu H, Liu
J, Saiyin H, Wu J, Huang H, Jiang S and Yu L: Reticulocalbin-2
enhances hepatocellular carcinoma proliferation via modulating the
EGFR-ERK pathway. Oncogene. 36:6691–6700. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang G, Zhang ZJ, Jian WG, Liu PH, Xue W,
Wang TD, Meng YY, Yuan C, Li HM, Yu YP, et al: Novel long noncoding
RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell
renal cell carcinoma proliferation via the Wnt/β-catenin signaling
pathway. Mol Cancer. 18:152019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meng J, Zhang XT, Liu XL, Fan L, Li C, Sun
Y, Liang XH, Wang JB, Mei QB, Zhang F and Zhang T: WSTF promotes
proliferation and invasion of lung cancer cells by inducing EMT via
PI3K/Akt and IL-6/STAT3 signaling pathways. Cell Signal.
28:1673–1682. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang W, Pan Q, Fuhler GM, Smits R and
Peppelenbosch MP: Action and function of Wnt/β-catenin signaling in
the progression from chronic hepatitis C to hepatocellular
carcinoma. J Gastroenterol. 52:419–431. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang R, Yu Z, Chen F, Xu H, Shen S, Chen
W, Chen L, Su Q, Zhang L, Bi J, et al: miR-300 regulates the
epithelial-mesenchymal transition and invasion of hepatocellular
carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Biomed
Pharmacother. 103:1632–1642. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y,
Zhang Y, Hua S, Fu Q, Zhao M, et al: Downregulation of FAP
suppresses cell proliferation and metastasis through PTEN/PI3K/AKT
and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death
Dis. 5:e11552014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Z, Zhou ZY, He CC, Zhang JL, Wang J
and Xiao ZY: Down-regulation of LncRNA NR027113 inhibits cells
proliferration and metastasis via PTEN/PI3K/Akt signaling pathway
in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci.
22:7222–7232. 2018.PubMed/NCBI
|
|
37
|
Chaturvedi VK, Singh A, Dudey SK, Hetta
HF, John J and Singh MP: Molecular mechanistic insight of hepatitis
B virus mediated hepatocellular carcinoma. Microb Pathog.
128:184–194. 2019. View Article : Google Scholar : PubMed/NCBI
|
